Company profile: Dualsystems Biotech
1.1 - Company Overview
Company description
- Provider of proteomic services for industry and academia, offering mass spectrometry-based proteomics and ligand-receptor interaction platforms: LRC-TriCEPS to identify interactions on living cells for drug discovery and receptor identification, and HATRIC-LRC to find receptors for orphan ligands. Swiss biotech founded in 2000 with yeast two-hybrid technologies.
Products and services
- Mass Spectrometry-Based Proteomics Services: delivers research-grade proteomic services for industry and academia using mass spectrometry-based proteomics technologies, a major pillar of the company’s expertise
- LRC-TriCEPS: a cell-compatible technology platform used to identify ligand-receptor interactions on living cells, aiding in drug discovery and receptor identification
- HATRIC-LRC: a targeted platform for identifying receptors for orphan ligands, facilitating the study of ligand-receptor interactions.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dualsystems Biotech
Rebus Biosystems
HQ: United States
Website
- Description: Provider of spatial omics tools: Rebus Esper for single-cell data at subcellular resolution; Esper High Fidelity assay for spatial transcriptomics (up to 30 custom genes without barcoding or enzymatic amplification); Esper High Plex assay enabling analysis of 1230 gene panels; SAO microscopy enhancing resolution without sacrificing throughput; plus the Esper Service Program providing processed gene images and a spatially annotated CellxFeature matrix.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rebus Biosystems company profile →
A4Cell
HQ: Spain
Website
- Description: Provider of SPAchip technology using intracellular silicon microchips to monitor living single cells and cellular pathways in real time without affecting viability. Offers kits: CytoCHECK pH Green, pH Red, Calcium; CytoTRACK pH Dual-Detection; and SpheroCHECK pH Green for 3D spheroids, enabling precise single-cell physiology monitoring to improve cell study data for understanding disease behavior.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full A4Cell company profile →
Cube Biotech
HQ: Germany
Website
- Description: Provider of tools and services for membrane protein research, offering cell-free protein expression, synthetic polymer and MSP nanodiscs for stabilization and purification, ultrapure detergents, protein purification products (agarose and magnetic beads), and purified membrane proteins. Germany-based, operating a two-pillared model with service and product units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cube Biotech company profile →
Seraxis
HQ: United States
Website
- Description: Provider of cell replacement therapy and lab-grown pancreatic islets for insulin-dependent diabetes. Offerings include SR-01, which combines lab-grown human islets with a technology to implant these islets without immune suppression; SR1423, a stem cell line maturing into insulin-secreting islets; and lab-grown islets that mimic native pancreatic function and respond to glucose.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seraxis company profile →
Mabtech
HQ: Sweden
Website
- Description: Provider of monoclonal antibodies and immunoassay kits for ELISA, ELISpot, and FluoroSpot; automated readers (Mabtech IRIS 2 for ELISpot, FluoroSpot, and FociSpot; Mabtech ASTOR 2 for ELISpot) for spot counting and data analysis; and reagents including peptide pools, polyclonal stimuli, buffers, substrates, plates, and antibodies to cytokines, immunoglobulins, and apolipoproteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mabtech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dualsystems Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dualsystems Biotech
2.2 - Growth funds investing in similar companies to Dualsystems Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dualsystems Biotech
4.2 - Public trading comparable groups for Dualsystems Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →